CH487181A - Verfahren zur Herstellung von antibakteriellen Agentien - Google Patents
Verfahren zur Herstellung von antibakteriellen AgentienInfo
- Publication number
- CH487181A CH487181A CH15068A CH15068A CH487181A CH 487181 A CH487181 A CH 487181A CH 15068 A CH15068 A CH 15068A CH 15068 A CH15068 A CH 15068A CH 487181 A CH487181 A CH 487181A
- Authority
- CH
- Switzerland
- Prior art keywords
- manufacture
- antibacterial agents
- antibacterial
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60737867A | 1967-01-05 | 1967-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH487181A true CH487181A (de) | 1970-03-15 |
Family
ID=24432009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH15068A CH487181A (de) | 1967-01-05 | 1968-01-05 | Verfahren zur Herstellung von antibakteriellen Agentien |
Country Status (11)
Country | Link |
---|---|
AT (1) | AT276626B (da) |
BE (1) | BE709019A (da) |
CH (1) | CH487181A (da) |
DE (1) | DE1670301C3 (da) |
DK (1) | DK126595B (da) |
FR (2) | FR1580837A (da) |
GB (1) | GB1213571A (da) |
IL (1) | IL29235A (da) |
NL (1) | NL6800176A (da) |
NO (1) | NO140269C (da) |
SE (1) | SE349564B (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE758764A (fr) * | 1969-11-13 | 1971-05-10 | Bristol Myers Co | Procede de preparation d'agents antibacteriens |
US3631027A (en) * | 1970-03-27 | 1971-12-28 | Bristol Myers Co | Cephalosporanic acids |
JPS5854157B2 (ja) * | 1977-06-10 | 1983-12-02 | 山之内製薬株式会社 | セフアロスポリン化合物の新規誘導体ならびにその製造方法 |
CH648317A5 (de) | 1977-06-10 | 1985-03-15 | Yamanouchi Pharma Co Ltd | 7alpha-methoxy-7betha-(1,3-dithietan-2- carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung. |
IT1141406B (it) * | 1980-04-01 | 1986-10-01 | Dob Far Spa | Sali della cefapirina con aminoacidi |
GB2122603A (en) * | 1982-06-25 | 1984-01-18 | Lark Spa | 7-Ä???-(substituted-thio)-acylamidoÜ-cephalosporanic acids |
US6369049B1 (en) | 1998-04-30 | 2002-04-09 | Eli Lilly And Company | Treatment of mastitis |
-
1967
- 1967-12-28 IL IL2923567A patent/IL29235A/xx unknown
-
1968
- 1968-01-03 DE DE19681670301 patent/DE1670301C3/de not_active Expired
- 1968-01-03 DK DK1368A patent/DK126595B/da not_active IP Right Cessation
- 1968-01-04 NO NO3568A patent/NO140269C/no unknown
- 1968-01-05 AT AT13268A patent/AT276626B/de active
- 1968-01-05 BE BE709019D patent/BE709019A/xx not_active IP Right Cessation
- 1968-01-05 GB GB871/68A patent/GB1213571A/en not_active Expired
- 1968-01-05 CH CH15068A patent/CH487181A/de not_active IP Right Cessation
- 1968-01-05 FR FR1580837D patent/FR1580837A/fr not_active Expired
- 1968-01-05 SE SE14068A patent/SE349564B/xx unknown
- 1968-01-05 NL NL6800176A patent/NL6800176A/xx unknown
- 1968-02-02 FR FR138533A patent/FR8381M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1670301C3 (de) | 1975-12-18 |
GB1213571A (en) | 1970-11-25 |
BE709019A (da) | 1968-07-05 |
DK126595B (da) | 1973-07-30 |
FR8381M (da) | 1971-03-01 |
DE1670301A1 (de) | 1972-02-24 |
NL6800176A (da) | 1968-07-08 |
IL29235A (en) | 1971-10-20 |
SE349564B (da) | 1972-10-02 |
FR1580837A (da) | 1969-09-12 |
NO140269C (no) | 1979-08-01 |
AT276626B (de) | 1969-11-25 |
DE1670301B2 (de) | 1975-05-07 |
NO140269B (no) | 1979-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH498825A (de) | Verfahren zur Herstellung von 2-C-Methyl-nukleosiden | |
AT306765B (de) | Verfahren zur Herstellung von Ferrovanadin | |
AT281778B (de) | Verfahren zur Herstellung von Alk-3-en-1-olen | |
AT283594B (de) | Verfahren zur Herstellung von 7-Halogen-octopyranosiden | |
CH489510A (de) | Verfahren zur Herstellung von substituierten v-Triazolen | |
AT279602B (de) | Verfahren zur Herstellung von Pyrrol-3-yl-ketonen | |
CH498142A (de) | Verfahren zur Herstellung von substituierten Piperidino-alkylthianaphthenen und -benzofuranen | |
CH499541A (de) | Verfahren zur Herstellung von Pyridyl-benzopyranen | |
CH507326A (de) | Verfahren zur Herstellung von Poly-e-caproamid | |
CH502292A (de) | Verfahren zur Herstellung von o-Isopropylaminobenzophenonen | |
CH505096A (de) | Verfahren zur Herstellung von substituierten p-Hydroxyphenylhydrazonen | |
AT283357B (de) | Verfahren zur Herstellung von 2-Aryl-v-triazolen | |
CH502993A (de) | Verfahren zur Herstellung von Ketonitrilen | |
CH487181A (de) | Verfahren zur Herstellung von antibakteriellen Agentien | |
CH483425A (de) | Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden | |
AT278001B (de) | Verfahren zur Herstellung von N-Trityl-imidazolen | |
CH484930A (de) | Verfahren zur Herstellung von Aryloxazolen | |
AT281420B (de) | Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen | |
CH513884A (de) | Verfahren zur Herstellung von Tetrahydro-Chinoxalin-2-onen | |
CH497438A (de) | Verfahren zur Herstellung von Difluor-s-triazinen | |
AT280309B (de) | Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen | |
CH498114A (de) | Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen | |
CH483396A (de) | Verfahren zur Herstellung von 1-Brom-4-acylamino-anthrachinonen | |
CH499492A (de) | Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen | |
CH496000A (de) | Verfahren zur Herstellung von Benzimidazol-N-Oxyden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |